Cytosorbents (CTSO) Return on Capital Employed Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 216.00 |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | -4,507.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,507.00 |
| Mar 31, 2026 | -1,348.00 |
| Dec 31, 2025 | 173.00 |
| Sep 30, 2025 | 1,563.00 |
| Jun 30, 2025 | 2,176.00 |
| Mar 31, 2025 | 3,515.00 |
| Dec 31, 2024 | 4,258.00 |
| Sep 30, 2024 | 2,038.00 |
| Jun 30, 2024 | 479.00 |
| Mar 31, 2024 | -1,288.00 |
| Dec 31, 2023 | -2,671.00 |
| Sep 30, 2023 | -1,211.00 |
| Jun 30, 2023 | -1,966.00 |
| Mar 31, 2023 | -2,354.00 |
| Dec 31, 2022 | -3,050.00 |
| Sep 30, 2022 | -4,285.00 |
| Jun 30, 2022 | -3,158.00 |
| Mar 31, 2022 | -2,499.00 |
| Dec 31, 2021 | -1,701.00 |
| Sep 30, 2021 | 368.00 |